http://www.raredr.com/news/neod00-vital-amyloidosis-study
NEOD001 and AL Amyloidosis





Michaela Liedtke, MD of Stanford University of Medicine discusses the pathophysiology of AL Amyloidosis and how NEOD001 may provide benefit to those patients.

The VITAL Amyloidosis study is currently recruiting patients. To learn more, visit clinicaltrials.gov/ct2/show/NCT02312206
Printer Printing...
$content$